Phoenicis Therapeutics
PrivateLast Round
VC Round
Aug 11, 2022
Company Overview
Phoenicis Therapeutics is a biotechnology company that develops recombinant protein-based therapies for rare, genetic, and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phoenicis Therapeutics Comparables
Compare Phoenicis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nova Anchora | 86% | |
| CSA Biotechnologies | 83% | |
| Aegle Therapeutics Corp | 82% |
Phoenicis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 11, 2022 |
Phoenicis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | VC Round |
| Congressionally Directed Medical Research Programs | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2022
$20M round from Cure EB and others.
Phoenicis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phoenicis Therapeutics's valuation, stock price, and market status.
Is Phoenicis Therapeutics a public or private company?
Phoenicis Therapeutics is a private company.
What is the current stock price of Phoenicis Therapeutics?
Phoenicis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Phoenicis Therapeutics worth (valuation)?
Valuation information for Phoenicis Therapeutics is not publicly available.
Can I buy Phoenicis Therapeutics stock?
Phoenicis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Phoenicis Therapeutics's last funding round?
Phoenicis Therapeutics's most recent funding round was VC Round on August 11, 2022.
Who are the main investors in Phoenicis Therapeutics?
Key investors in Phoenicis Therapeutics include CureDuchenne Ventures, Congressionally Directed Medical Research Programs.
Will Phoenicis Therapeutics IPO soon?
No public IPO plans have been announced for Phoenicis Therapeutics.
How can I track Phoenicis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phoenicis Therapeutics's secondary market activity and sign up for updates.